Mark R Player Selected Research

Drug-Related Side Effects and Adverse Reactions

1/2018

Discovery of novel benzo[b]thiophene tetrazoles as non-carboxylate GPR40 agonists.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mark R Player Research Topics

Disease

3	Pain (Aches) 05/2015 - 08/2008
3	Arthritis (Polyarthritis) 11/2011 - 03/2008
2	Chemical and Drug Induced Liver Injury 01/2019 - 01/2018
2	Body Weight (Weight, Body) 01/2019 - 02/2011
2	Obesity 09/2017 - 02/2011
2	Insulin Resistance 09/2017 - 02/2011
2	Thrombosis (Thrombus) 02/2010 - 05/2008
2	Inflammation (Inflammations) 02/2009 - 01/2009
2	Neoplasms (Cancer) 01/2009 - 12/2008
1	Weight Loss (Weight Reduction) 01/2019
1	Necrosis 01/2018
1	Hypertrophy 01/2018
1	Drug-Related Side Effects and Adverse Reactions 01/2018
1	Hypersensitivity (Allergy) 05/2015
1	Hypothermia 05/2014
1	Heart Arrest (Cardiac Arrest) 05/2014
1	Brain Ischemia (Cerebral Ischemia) 05/2014
1	Ischemia 11/2013
1	Stroke (Strokes) 11/2013
1	Tachycardia (Tachyarrhythmias) 11/2013
1	Hyperalgesia 03/2012
1	Thromboembolism 03/2011
1	Hemorrhage 03/2011
1	Venous Thrombosis (Deep-Vein Thrombosis) 02/2010
1	Rheumatoid Arthritis 01/2009

Drug/Important Bio-Agent (IBA)

3	Thrombin FDA Link 03/2011 - 05/2008
2	Insulin (Novolin)FDA Link 01/2019 - 02/2011
2	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 09/2017
2	Carboxylic AcidsIBA 01/2019 - 01/2018
2	Triglycerides (Triacylglycerol)IBA 09/2017 - 02/2011
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2019
1	FluorineIBA 01/2019
1	TAK-875IBA 01/2018
1	Bile Acids and Salts (Bile Acids)IBA 01/2018
1	BilirubinIBA 01/2018
1	Rosiglitazone (Avandia)FDA Link 09/2017
1	Freund's AdjuvantIBA 05/2015
1	imidazoleIBA 05/2015
1	Capsaicin (Zostrix)FDA Link 05/2015
1	CarrageenanIBA 05/2015
1	mavatrepIBA 05/2015
1	Transient Receptor Potential ChannelsIBA 05/2014
1	Ion Channels (Ion Channel)IBA 11/2013
1	benzimidazoleIBA 03/2012
1	Collagen Type II (Type II Collagen)IBA 11/2011
1	4- cyano- N- (2- (1- cyclohexen- 1- yl)- 4- (1- ((dimethylamino)acetyl)- 4- piperidinyl)phenyl)- 1H- imidazole- 2- carboxamideIBA 11/2011
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 03/2011
1	AnticoagulantsIBA 03/2011
1	Bradykinin B1 Receptor AntagonistsIBA 08/2010
1	1- (N- (2- (Amidinoaminooxy)ethyl)amino)carbonylmethyl- 6- methyl- 3- (2,2- difluoro- 2- phenylethylamino)pyrazinoneIBA 02/2010
1	Dihydrotachysterol (AT 10)IBA 02/2009
1	Macrophage Colony-Stimulating FactorIBA 01/2009
1	Proteins (Proteins, Gene)FDA Link 12/2008
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 12/2008
1	Oncogene Proteins (Oncogene Protein)IBA 12/2008
1	piperidineIBA 08/2008
1	CollagenIBA 03/2008
1	Phosphotransferases (Kinase)IBA 03/2008

Therapy/Procedure

4	Oral Administration 09/2017 - 05/2008
2	Induced Hypothermia 05/2014 - 11/2013
1	Therapeutics 12/2008